English

MATRIX PHARMACEUTICAL INC/DE

EDGAR

Quarterly report (10-Q) · filed 2001-11-09

24 filing records in this dataset, filed from 1996-05-08 to 2001-11-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2000-06-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-5.12 million USD

2000-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -11689000 USD Source
Operating Cash Flow: -6569000 USD Source

Free cash flow

-5.27 million USD

2000-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -11689000 USD Source
Operating Cash Flow: -6569000 USD Source
Capital Expenditure: 255000 USD Source
Capital Expenditure: 106000 USD Source

Cash and cash equivalents: 17.7 million USD 2001-09-30 Source
Exact value

17738000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

1999-07-01 – 2000-06-30

Exact inputs and evidence

Revenue: 0 USD · 1999-07-01 – 1999-09-30 Source
Revenue: 0 USD · 1999-01-01 – 1999-12-31 Source
Revenue: 0 USD · 1999-01-01 – 1999-09-30 Source
Revenue: 0 USD · 2000-01-01 – 2000-03-31 Source
Revenue: 0 USD · 2000-04-01 – 2000-06-30 Source

Net income

-29.3 million USD

2000-10-01 – 2001-09-30

Exact inputs and evidence

Net income: -23321000 USD · 2000-01-01 – 2000-12-31 Source
Net income: -16529000 USD · 2000-01-01 – 2000-09-30 Source
Net income: -6624000 USD · 2001-01-01 – 2001-03-31 Source
Net income: -8036000 USD · 2001-04-01 – 2001-06-30 Source
Net income: -7838000 USD · 2001-07-01 – 2001-09-30 Source

Operating cash flow

-30 million USD

2000-10-01 – 2001-09-30

Exact inputs and evidence

Operating cash flow: -23637000 USD · 2000-01-01 – 2000-12-31 Source
Operating cash flow: -16297000 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -7318000 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -14773000 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: -7318000 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -22663000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -14773000 USD · 2001-01-01 – 2001-06-30 Source

Capital expenditure

839 thousand USD

2000-10-01 – 2001-09-30

Exact inputs and evidence

Capital expenditure: 541000 USD · 2000-01-01 – 2000-12-31 Source
Capital expenditure: 384000 USD · 2000-01-01 – 2000-09-30 Source
Capital expenditure: 268000 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 362000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 268000 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 682000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 362000 USD · 2001-01-01 – 2001-06-30 Source

Free cash flow

-30.8 million USD

2000-10-01 – 2001-09-30

Exact inputs and evidence

Operating cash flow: -23637000 USD · 2000-01-01 – 2000-12-31 Source
Operating cash flow: -16297000 USD · 2000-01-01 – 2000-09-30 Source
Operating cash flow: -7318000 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -14773000 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: -7318000 USD · 2001-01-01 – 2001-03-31 Source
Operating cash flow: -22663000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -14773000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 541000 USD · 2000-01-01 – 2000-12-31 Source
Capital expenditure: 384000 USD · 2000-01-01 – 2000-09-30 Source
Capital expenditure: 268000 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 362000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 268000 USD · 2001-01-01 – 2001-03-31 Source
Capital expenditure: 682000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 362000 USD · 2001-01-01 – 2001-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2001-11-09.

Financial data available through: 1999-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 1999-12-31
Operating income: 6 of 11 periods available· newest 1999-12-31
Net income: 6 of 11 periods available· newest 1999-12-31
Operating cash flow: 6 of 11 periods available· newest 1999-12-31
Capital expenditure: 6 of 11 periods available· newest 1999-12-31
Total assets: 6 of 11 periods available· newest 1999-12-31
liabilities: No compatible figures in this window
Current assets: 5 of 11 periods available· newest 1999-12-31
Current liabilities: 5 of 11 periods available· newest 1999-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 1999-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

1998-01-01 – 1998-12-31
Current period

USD 0

1999-01-01 – 1999-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
0 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MATRIX PHARMACEUTICAL INC/DE · 1999-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-00-011392.txt#3744 Input fundies:Revenue: 0 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0001047469-99-011511.txt#2583
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 351,000

Prior period

−USD 21.35 million

1998-01-01 – 1998-12-31
Current period

−USD 21 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

-20998000 − -21349000 = 351000 USD

-21349000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
-20998000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MATRIX PHARMACEUTICAL INC/DE · 1999-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Year-over-year change in Net income: 351000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -20998000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2906 Input fundies:NetIncome: -21349000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2906
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 5.94 million

Prior period

−USD 25.1 million

1998-01-01 – 1998-12-31
Current period

−USD 19.16 million

1999-01-01 – 1999-12-31

Exact inputs and evidence

-19156000 − -25097000 = 5941000 USD

-25097000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
-19156000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MATRIX PHARMACEUTICAL INC/DE · 1999-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Year-over-year change in Operating cash flow: 5941000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -19156000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2926 Input fundies:OperatingCashFlow: -25097000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2926
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-60.8%

Prior period

USD 1.02 million

1998-01-01 – 1998-12-31
Current period

USD 398,000

1999-01-01 – 1999-12-31

Exact inputs and evidence

398000 − 1016000 = -618000 USD

1016000 USD · 1998-01-01 – 1998-12-31
Inspect prior input Prior source
398000 USD · 1999-01-01 – 1999-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · MATRIX PHARMACEUTICAL INC/DE · 1999-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Year-over-year change in Capital expenditure: -618000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 398000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2928 Input fundies:CapitalExpenditure: 1016000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2928
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1999 1999-01-01 – 1999-12-31

Revenue USD 0
Operating costs Derived USD 23.11 million
Operating income −USD 23.11 million
Tax, interest and other Derived −USD 2.11 million
Net income −USD 21 million

Cash

Operating cash flow −USD 19.16 million
Capital expenditure USD 398,000
Free cash flow Derived −USD 19.55 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Net loss: net income was −19,588% of revenue.
1995 Not shown: operating income or net income is not reported.
1996 Not shown: operating income or net income is not reported.
1997 Not shown: operating income or net income is not reported.
1998 Not shown: operating income or net income is not reported.
1999 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	100000	-20678000 Derived	20778000	40366000 Derived	-19588000	-17975000 Derived	Source 1994-01-01 – 1994-12-31: 100000 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: 20778000 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: -19588000 USD Inspect Net Income Open source 1994-01-01 – 1994-12-31: -17451000 USD Inspect Operating Cash Flow Open source 1994-01-01 – 1994-12-31: 524000 USD Inspect Capital Expenditure Open source
1995 1995-01-01 – 1995-12-31	0	28592000 Derived	-28592000	-1975000 Derived	-26617000	-36259000 Derived	Source 1995-01-01 – 1995-12-31: 0 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -28592000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -26617000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -21355000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 14904000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	0	35748000 Derived	-35748000	-6105000 Derived	-29643000	-30861000 Derived	Source 1996-01-01 – 1996-12-31: 0 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -35748000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -29643000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -28535000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 2326000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	0	46002000 Derived	-46002000	-6271000 Derived	-39731000	-44226000 Derived	Source 1997-01-01 – 1997-12-31: 0 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -46002000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -39731000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -34369000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 9857000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	0	30835000 Derived	-30835000	-9486000 Derived	-21349000	-26113000 Derived	Source 1998-01-01 – 1998-12-31: 0 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -30835000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -21349000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -25097000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 1016000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	0	23105000 Derived	-23105000	-2107000 Derived	-20998000	-19554000 Derived	Source 1999-01-01 – 1999-12-31: 0 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -23105000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -20998000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -19156000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 398000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 1999

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	100000	Revenue: 100000 Open source
19951995-12-31	Revenue	0	Revenue: 0 Open source
19961996-12-31	Revenue	0	Revenue: 0 Open source
19971997-12-31	Revenue	0	Revenue: 0 Open source
19981998-12-31	Revenue	0	Revenue: 0 Open source
19991999-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 1995

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 100000 Open source
19951995-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 100000 Open source
19961996-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
19971997-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
19981998-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
19991999-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 20,778% 1994

Net margin -19,588% 1994

Free cash flow margin -17,975% 1994

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Operating margin	20,778%	Operating Income: 20778000 Open source Revenue: 100000 Open source
19951995-12-31	Operating margin	Not reported	Operating Income: -28592000 Open source Revenue: 0 Open source
19961996-12-31	Operating margin	Not reported	Operating Income: -35748000 Open source Revenue: 0 Open source
19971997-12-31	Operating margin	Not reported	Operating Income: -46002000 Open source Revenue: 0 Open source
19981998-12-31	Operating margin	Not reported	Operating Income: -30835000 Open source Revenue: 0 Open source
19991999-12-31	Operating margin	Not reported	Operating Income: -23105000 Open source Revenue: 0 Open source
19941994-12-31	Net margin	-19,588%	Net Income: -19588000 Open source Revenue: 100000 Open source
19951995-12-31	Net margin	Not reported	Net Income: -26617000 Open source Revenue: 0 Open source
19961996-12-31	Net margin	Not reported	Net Income: -29643000 Open source Revenue: 0 Open source
19971997-12-31	Net margin	Not reported	Net Income: -39731000 Open source Revenue: 0 Open source
19981998-12-31	Net margin	Not reported	Net Income: -21349000 Open source Revenue: 0 Open source
19991999-12-31	Net margin	Not reported	Net Income: -20998000 Open source Revenue: 0 Open source
19941994-12-31	Free cash flow margin	-17,975%	Revenue: 100000 Open source Operating Cash Flow: -17451000 Open source Capital Expenditure: 524000 Open source
19951995-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -21355000 Open source Capital Expenditure: 14904000 Open source
19961996-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -28535000 Open source Capital Expenditure: 2326000 Open source
19971997-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -34369000 Open source Capital Expenditure: 9857000 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -25097000 Open source Capital Expenditure: 1016000 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -19156000 Open source Capital Expenditure: 398000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -19.2M 1999

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	-17451000	Operating Cash Flow: -17451000 Open source
19951995-12-31	Operating cash flow	-21355000	Operating Cash Flow: -21355000 Open source
19961996-12-31	Operating cash flow	-28535000	Operating Cash Flow: -28535000 Open source
19971997-12-31	Operating cash flow	-34369000	Operating Cash Flow: -34369000 Open source
19981998-12-31	Operating cash flow	-25097000	Operating Cash Flow: -25097000 Open source
19991999-12-31	Operating cash flow	-19156000	Operating Cash Flow: -19156000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -19.6M 1999

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	-17975000	Operating Cash Flow: -17451000 Open source Capital Expenditure: 524000 Open source
19951995-12-31	Free cash flow	-36259000	Operating Cash Flow: -21355000 Open source Capital Expenditure: 14904000 Open source
19961996-12-31	Free cash flow	-30861000	Operating Cash Flow: -28535000 Open source Capital Expenditure: 2326000 Open source
19971997-12-31	Free cash flow	-44226000	Operating Cash Flow: -34369000 Open source Capital Expenditure: 9857000 Open source
19981998-12-31	Free cash flow	-26113000	Operating Cash Flow: -25097000 Open source Capital Expenditure: 1016000 Open source
19991999-12-31	Free cash flow	-19554000	Operating Cash Flow: -19156000 Open source Capital Expenditure: 398000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Liabilities / assets	Not reported	Total Assets: 37767000 Open source
1995-12-31	Liabilities / assets	Not reported	Total Assets: 94419000 Open source
1996-12-31	Liabilities / assets	Not reported	Total Assets: 134950000 Open source
1997-12-31	Liabilities / assets	Not reported	Total Assets: 110429000 Open source
1998-12-31	Liabilities / assets	Not reported	Total Assets: 83731000 Open source
1999-12-31	Liabilities / assets	Not reported	Total Assets: 61195000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.19× 1999

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	11.51×	Current Assets: 66273000 Open source Current Liabilities: 5757000 Open source
19961996-12-31	Current assets / current liabilities	8.06×	Current Assets: 62176000 Open source Current Liabilities: 7715000 Open source
19971997-12-31	Current assets / current liabilities	5.38×	Current Assets: 62513000 Open source Current Liabilities: 11615000 Open source
19981998-12-31	Current assets / current liabilities	7.98×	Current Assets: 69606000 Open source Current Liabilities: 8728000 Open source
19991999-12-31	Current assets / current liabilities	6.19×	Current Assets: 48776000 Open source Current Liabilities: 7883000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 19.59 million Exact value Exact value: -19588000 USD 1994-01-01 – 1994-12-31: -19588000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MATRIX PHARMACEUTICAL INC/DE · 1994-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Net Income: -19588000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19588000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000950005-97-000332.txt#3099 The citation records this snapshot. The page link may show a newer release later.	−USD 17.45 million Exact value Exact value: -17451000 USD 1994-01-01 – 1994-12-31: -17451000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MATRIX PHARMACEUTICAL INC/DE · 1994-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Operating Cash Flow: -17451000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17451000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000950005-97-000332.txt#3114 The citation records this snapshot. The page link may show a newer release later.	USD 524,000 Exact value Exact value: 524000 USD 1994-01-01 – 1994-12-31: 524000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MATRIX PHARMACEUTICAL INC/DE · 1994-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Capital Expenditure: 524000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 524000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000950005-97-000332.txt#3116 The citation records this snapshot. The page link may show a newer release later.	−USD 17.98 million Calculation and evidence -17451000 − 524000 USD Exact free cash flow: -17975000 USD 1994-01-01 – 1994-12-31: -17451000 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 524000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MATRIX PHARMACEUTICAL INC/DE · 1994-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Free cash flow: -17975000 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17451000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000950005-97-000332.txt#3114 Input fundies:CapitalExpenditure: 524000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000950005-97-000332.txt#3116 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 26.62 million Exact value Exact value: -26617000 USD 1995-01-01 – 1995-12-31: -26617000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MATRIX PHARMACEUTICAL INC/DE · 1995-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Net Income: -26617000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26617000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000950005-98-000326.txt#2641 The citation records this snapshot. The page link may show a newer release later.	−USD 21.36 million Exact value Exact value: -21355000 USD 1995-01-01 – 1995-12-31: -21355000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MATRIX PHARMACEUTICAL INC/DE · 1995-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Operating Cash Flow: -21355000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21355000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000950005-98-000326.txt#2660 The citation records this snapshot. The page link may show a newer release later.	USD 14.9 million Exact value Exact value: 14904000 USD 1995-01-01 – 1995-12-31: 14904000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MATRIX PHARMACEUTICAL INC/DE · 1995-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Capital Expenditure: 14904000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 14904000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000950005-98-000326.txt#2662 The citation records this snapshot. The page link may show a newer release later.	−USD 36.26 million Calculation and evidence -21355000 − 14904000 USD Exact free cash flow: -36259000 USD 1995-01-01 – 1995-12-31: -21355000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 14904000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MATRIX PHARMACEUTICAL INC/DE · 1995-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Free cash flow: -36259000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21355000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000950005-98-000326.txt#2660 Input fundies:CapitalExpenditure: 14904000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000950005-98-000326.txt#2662 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 29.64 million Exact value Exact value: -29643000 USD 1996-01-01 – 1996-12-31: -29643000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MATRIX PHARMACEUTICAL INC/DE · 1996-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Net Income: -29643000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29643000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0001047469-99-011511.txt#2837 The citation records this snapshot. The page link may show a newer release later.	−USD 28.54 million Exact value Exact value: -28535000 USD 1996-01-01 – 1996-12-31: -28535000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MATRIX PHARMACEUTICAL INC/DE · 1996-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Operating Cash Flow: -28535000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -28535000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0001047469-99-011511.txt#2857 The citation records this snapshot. The page link may show a newer release later.	USD 2.33 million Exact value Exact value: 2326000 USD 1996-01-01 – 1996-12-31: 2326000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MATRIX PHARMACEUTICAL INC/DE · 1996-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Capital Expenditure: 2326000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2326000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0001047469-99-011511.txt#2859 The citation records this snapshot. The page link may show a newer release later.	−USD 30.86 million Calculation and evidence -28535000 − 2326000 USD Exact free cash flow: -30861000 USD 1996-01-01 – 1996-12-31: -28535000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 2326000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MATRIX PHARMACEUTICAL INC/DE · 1996-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Free cash flow: -30861000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -28535000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0001047469-99-011511.txt#2857 Input fundies:CapitalExpenditure: 2326000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0001047469-99-011511.txt#2859 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 39.73 million Exact value Exact value: -39731000 USD 1997-01-01 – 1997-12-31: -39731000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MATRIX PHARMACEUTICAL INC/DE · 1997-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Net Income: -39731000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -39731000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0001047469-99-011511.txt#2837 The citation records this snapshot. The page link may show a newer release later.	−USD 34.37 million Exact value Exact value: -34369000 USD 1997-01-01 – 1997-12-31: -34369000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MATRIX PHARMACEUTICAL INC/DE · 1997-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Operating Cash Flow: -34369000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -34369000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0001047469-99-011511.txt#2857 The citation records this snapshot. The page link may show a newer release later.	USD 9.86 million Exact value Exact value: 9857000 USD 1997-01-01 – 1997-12-31: 9857000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MATRIX PHARMACEUTICAL INC/DE · 1997-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Capital Expenditure: 9857000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9857000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0001047469-99-011511.txt#2859 The citation records this snapshot. The page link may show a newer release later.	−USD 44.23 million Calculation and evidence -34369000 − 9857000 USD Exact free cash flow: -44226000 USD 1997-01-01 – 1997-12-31: -34369000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 9857000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MATRIX PHARMACEUTICAL INC/DE · 1997-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Free cash flow: -44226000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -34369000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0001047469-99-011511.txt#2857 Input fundies:CapitalExpenditure: 9857000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0001047469-99-011511.txt#2859 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 21.35 million Exact value Exact value: -21349000 USD 1998-01-01 – 1998-12-31: -21349000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MATRIX PHARMACEUTICAL INC/DE · 1998-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Net Income: -21349000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21349000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2906 The citation records this snapshot. The page link may show a newer release later.	−USD 25.1 million Exact value Exact value: -25097000 USD 1998-01-01 – 1998-12-31: -25097000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MATRIX PHARMACEUTICAL INC/DE · 1998-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Operating Cash Flow: -25097000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25097000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2926 The citation records this snapshot. The page link may show a newer release later.	USD 1.02 million Exact value Exact value: 1016000 USD 1998-01-01 – 1998-12-31: 1016000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MATRIX PHARMACEUTICAL INC/DE · 1998-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Capital Expenditure: 1016000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1016000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2928 The citation records this snapshot. The page link may show a newer release later.	−USD 26.11 million Calculation and evidence -25097000 − 1016000 USD Exact free cash flow: -26113000 USD 1998-01-01 – 1998-12-31: -25097000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 1016000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MATRIX PHARMACEUTICAL INC/DE · 1998-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Free cash flow: -26113000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25097000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2926 Input fundies:CapitalExpenditure: 1016000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2928 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 21 million Exact value Exact value: -20998000 USD 1999-01-01 – 1999-12-31: -20998000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MATRIX PHARMACEUTICAL INC/DE · 1999-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Net Income: -20998000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -20998000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2906 The citation records this snapshot. The page link may show a newer release later.	−USD 19.16 million Exact value Exact value: -19156000 USD 1999-01-01 – 1999-12-31: -19156000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MATRIX PHARMACEUTICAL INC/DE · 1999-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Operating Cash Flow: -19156000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19156000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2926 The citation records this snapshot. The page link may show a newer release later.	USD 398,000 Exact value Exact value: 398000 USD 1999-01-01 – 1999-12-31: 398000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · MATRIX PHARMACEUTICAL INC/DE · 1999-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Capital Expenditure: 398000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 398000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2928 The citation records this snapshot. The page link may show a newer release later.	−USD 19.55 million Calculation and evidence -19156000 − 398000 USD Exact free cash flow: -19554000 USD 1999-01-01 – 1999-12-31: -19156000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 398000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · MATRIX PHARMACEUTICAL INC/DE · 1999-12-31 MATRIX PHARMACEUTICAL INC/DE (edgar:882194) Free cash flow: -19554000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T21:45:22Z Snapshot: 20b0f74aa3888d2c195918ddbd262aa7b37bc5237d922eb4c7a74c95c75930a2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/882194?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19156000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2926 Input fundies:CapitalExpenditure: 398000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/882194/0000912057-01-007616.txt#2928 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

24 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000882194, 882194, edgar:882194

MATRIX PHARMACEUTICAL INC/DE

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1999 1999-01-01 – 1999-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation